Cargando…

Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease (NAFLD) has been recognized as the most common liver disorder in developed countries. NAFLD progresses from fat accumulation in hepatocytes to steatohepatitis to further stages of fibrosis and cirrhosis. Simple steatosis, i.e. fat deposition in the liver, is conside...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakhani, Hari Vishal, Sharma, Dana, Dodrill, Michael W., Nawab, Athar, Sharma, Nitin, Cottrill, Cameron Lee, Shapiro, Joseph I., Sodhi, Komal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299410/ https://www.ncbi.nlm.nih.gov/pubmed/30588181 http://dx.doi.org/10.7150/ijms.27953

Ejemplares similares

Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis
por: Sharma, Dana L., et al.
Publicado: (2017)

Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
por: Tun, Steven, et al.
Publicado: (2020)

Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese Mice
por: Puri, Nitin, et al.
Publicado: (2017)

RETRACTED ARTICLE: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2019)

Author Correction: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2020)

Retraction Note: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2022)

Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
por: Pillai, Sneha S., et al.
Publicado: (2020)

Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population
por: Lakhani, Hari Vishal, et al.
Publicado: (2020)

Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet
por: Sodhi, Komal, et al.
Publicado: (2015)

Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population
por: Lakhani, Hari Vishal, et al.
Publicado: (2018)

Beneficial Role of HO-1-SIRT1 Axis in Attenuating Angiotensin II-Induced Adipocyte Dysfunction
por: Lakhani, Hari Vishal, et al.
Publicado: (2019)

Spin Trapping: A Review for the Study of Obesity Related Oxidative Stress and Na(+)/K(+)-ATPase
por: Nawab, Athar, et al.
Publicado: (2017)

Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models
por: Bartlett, David E., et al.
Publicado: (2018)

Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia
por: Al-Astal, Ala-Eddin Yassin, et al.
Publicado: (2022)

Role of Dietary Components in Modulating Hypertension
por: Feyh, Andrew, et al.
Publicado: (2016)

The Role of Na/K-ATPase Signaling in Oxidative Stress Related to Aging: Implications in Obesity and Cardiovascular Disease
por: Bartlett, David E., et al.
Publicado: (2018)

Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis
por: Pratt, Rebecca, et al.
Publicado: (2019)

Existence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia
por: Goguet-Rubio, Perrine, et al.
Publicado: (2017)

Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia
por: Pillai, Sneha S., et al.
Publicado: (2022)

Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis
por: Zehra, Mishghan, et al.
Publicado: (2020)

Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer
por: Lakhani, Hari Vishal, et al.
Publicado: (2021)

Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
por: Lyall, Marcus J., et al.
Publicado: (2018)

A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders
por: Perdoncin, Maddie, et al.
Publicado: (2021)

Prevalence of Substance Abuse Among Trauma Patients in Rural West Virginia
por: Mansoor, Kanaan, et al.
Publicado: (2023)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Increased HO-1 Levels Ameliorate Fatty Liver Development Through a Reduction of Heme and Recruitment of FGF21
por: Hinds, Terry D., et al.
Publicado: (2013)

AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease
por: Nikolaou, Nikolaos, et al.
Publicado: (2019)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
por: Pan, Xiaoli, et al.
Publicado: (2022)

Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Sodhi, Komal, et al.
Publicado: (2021)

Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Sodhi, Komal, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
por: Takeichi, Yukina, et al.
Publicado: (2021)

Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease
por: Zhang, Yizhi, et al.
Publicado: (2022)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
por: Jia, Lin, et al.
Publicado: (2018)

Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease
por: Han, Mei, et al.
Publicado: (2020)

Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice
por: Weiss, Jonathan M., et al.
Publicado: (2023)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues
por: Singla, Tanvi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rtvli0n5647umdrbivpnscjum3